Companies in Massachusetts

Page: 1 of 7
Region:   North America
Displaying 1-50 of 306 results Download this list
Name Symbol Market Cap ADR TSO Country IPO Year Subsector
THL Credit, Inc. n/a United States 2014 n/a
Tecogen Inc. $78.89M United States 2014 Industrial Machinery/Components
Flexion Therapeutics, Inc. $443.03M United States 2014 Major Pharmaceuticals
Genocea Biosciences, Inc. $132.78M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Concert Pharmaceuticals, Inc. $223.87M United States 2014 Major Pharmaceuticals
Eleven Biotherapeutics, Inc. $188.96M United States 2014 Major Pharmaceuticals
Aldeyra Therapeutics, Inc. $43.58M United States 2014 Major Pharmaceuticals
Dicerna Pharmaceuticals, Inc. $293.97M United States 2014 Major Pharmaceuticals
Cerulean Pharma Inc. $122.56M United States 2014 Major Pharmaceuticals
Akebia Therapeutics, Inc. $248.97M United States 2014 Major Pharmaceuticals
Melrose Bancorp, Inc. $37.07M United States 2014 Major Banks
Minerva Neurosciences, Inc $98.1M United States 2014 Major Pharmaceuticals
Histogenics Corporation $142.24M United States 2014 n/a
Tokai Pharmaceuticals, Inc. $335.73M United States 2014 Major Pharmaceuticals
T2 Biosystems, Inc. $354.54M United States 2014 Medical/Dental Instruments
Zafgen, Inc. $644.44M United States 2014 Major Pharmaceuticals
Sage Therapeutics, Inc. $1.05B United States 2014 Major Pharmaceuticals
Proteon Therapeutics, Inc. $172.72M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
CB Pharma Acquisition Corp. n/a United States 2014 n/a
Bright Horizons Family Solutions Inc. $3.08B United States 2013 Other Consumer Services
Enanta Pharmaceuticals, Inc. $954.76M United States 2013 Major Pharmaceuticals
Epizyme, Inc. $642.27M United States 2013 Major Pharmaceuticals
bluebird bio, Inc. $2.59B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Agios Pharmaceuticals, Inc. $4.47B United States 2013 Major Pharmaceuticals
Foundation Medicine, Inc. $690.18M United States 2013 Medical Specialities
BIND Therapeutics, Inc. $94.82M United States 2013 Major Pharmaceuticals
Endurance International Group Holdings, Inc. $2.47B United States 2013 Computer Software: Prepackaged Software
Acceleron Pharma Inc. $1.24B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Karyopharm Therapeutics Inc. $1.28B United States 2013 Major Pharmaceuticals
Houghton Mifflin Harcourt Company $2.89B United States 2013 Books
Affiliated Managers Group, Inc. n/a United States 2012 Investment Managers
Equity Commonwealth n/a United States 2012 Real Estate Investment Trusts
M/A-COM Technology Solutions Holdings, Inc. $1.52B United States 2012 Semiconductors
Brightcove Inc. $256.57M United States 2012 EDP Services
Wellesley Bancorp, Inc. $46.39M United States 2012 Banks
Exa Corporation $157.05M United States 2012 Computer Software: Prepackaged Software
Verastem, Inc. $217.25M United States 2012 Major Pharmaceuticals
TESARO, Inc. $1.36B United States 2012 Major Pharmaceuticals
Stag Industrial, Inc. $1.61B United States 2011 Real Estate Investment Trusts
Dunkin' Brands Group, Inc. $4.39B United States 2011 Restaurants
BSB Bancorp, Inc. $168.85M United States 2011 Major Banks
THL Credit, Inc. $391.27M United States 2010 n/a
AVEO Pharmaceuticals, Inc. $41.75M United States 2010 Major Pharmaceuticals
Ironwood Pharmaceuticals, Inc. $2.03B United States 2010 Major Pharmaceuticals
Peoples Federal Bancshares, Inc. $138.52M United States 2010 Banks
LPL Financial Holdings Inc. $4.37B United States 2010 Investment Bankers/Brokers/Service
Ameresco, Inc. $327.23M United States 2010 Engineering & Construction
Eaton Vance Municipal Income Trust $322.35M United States 2009 n/a
LogMein, Inc. $1.21B United States 2009 Computer Software: Prepackaged Software
Synta Pharmaceuticals Corp. $298.37M United States 2007 Major Pharmaceuticals
*IPO year information is not available for stocks prior to 1970.